More on EXEL by Philip Davis
Latest EXEL Transcript
-
Exelixis' Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
Thu, May 17
Latest EXEL Articles
-
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1
Thu, May 24 • StockPandit
-
6 Highly Shorted Takeover/LBO Targets Being Bought By Hedge Funds
Fri, May 18 • Kapitall
-
Biotech-Focused Baker Bros. $3.7B Fund Bought These 3 Big Winners And Sold Others In Q1
Thu, May 17 • Ganaxi Small Cap Movers
-
5% Fund Ownership Filings In Healthcare: 2 Surging And 2 Plunging Stocks Bought And 5 Others
Tue, May 15 • Ganaxi Small Cap Movers
-
For Dendreon There's A Little Light, But A Lot Of Tunnel
Tue, May 8 • Stephen Simpson
-
Exelixis: Uncovering Value
Mon, Apr 30 • David Sobek
-
Why The Markets Continue To Coalesce Around New Approaches To Treating Cancer
Thu, Apr 19 • Brett Korsgaard
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
Exelixis, Inc. (EXEL)
Posts on EXEL by Philip Davis
Personalized Medicine for the Masses
Posts on EXEL by other instabloggers
-
Sun, Mar 18
•
MagicDiligence
-
Fri, Jan 27
•
ivicaj
-
Fri, Jan 13
•
Kinetic Investments
-
Thu, Dec 22, 2011
•
Disclosure Insight
-
Wed, Aug 10, 2011
•
Investorideas.com
All instablog posts on EXEL »Magic Formula Investing Weekly Roundup 3/18/2012
VXX, EXEL
$50K Challenge Update
EXEL Terminates Second Collaboration Agreement
Biotech/Pharma Stocks Trading : AEMD, ANX, OXGN, CHTP, EXEL